Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinomaUğur Uslu, Carl H. June|Science Advances|2023Cited by 61
The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretionUğur Uslu, Carl H. June|Nature Communications|2024Cited by 50